185 related articles for article (PubMed ID: 37877240)
1. Rational Prediction of PROTAC-Compatible Protein-Protein Interfaces by Molecular Docking.
Pereira GP; Jiménez-García B; Pellarin R; Launay G; Wu S; Martin J; Souza PCT
J Chem Inf Model; 2023 Nov; 63(21):6823-6833. PubMed ID: 37877240
[TBL] [Abstract][Full Text] [Related]
2. High Accuracy Prediction of PROTAC Complex Structures.
Ignatov M; Jindal A; Kotelnikov S; Beglov D; Posternak G; Tang X; Maisonneuve P; Poda G; Batey RA; Sicheri F; Whitty A; Tonge PJ; Vajda S; Kozakov D
J Am Chem Soc; 2023 Apr; 145(13):7123-7135. PubMed ID: 36961978
[TBL] [Abstract][Full Text] [Related]
3. Kinetic Detection of E3:PROTAC:Target Ternary Complexes Using NanoBRET Technology in Live Cells.
Mahan SD; Riching KM; Urh M; Daniels DL
Methods Mol Biol; 2021; 2365():151-171. PubMed ID: 34432243
[TBL] [Abstract][Full Text] [Related]
4. PROTAC-DB 2.0: an updated database of PROTACs.
Weng G; Cai X; Cao D; Du H; Shen C; Deng Y; He Q; Yang B; Li D; Hou T
Nucleic Acids Res; 2023 Jan; 51(D1):D1367-D1372. PubMed ID: 36300631
[TBL] [Abstract][Full Text] [Related]
5. PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes.
Zaidman D; Prilusky J; London N
J Chem Inf Model; 2020 Oct; 60(10):4894-4903. PubMed ID: 32976709
[TBL] [Abstract][Full Text] [Related]
6. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.
Bai N; Riching KM; Makaju A; Wu H; Acker TM; Ou SC; Zhang Y; Shen X; Bulloch DN; Rui H; Gibson BW; Daniels DL; Urh M; Rock BM; Humphreys SC
J Biol Chem; 2022 Apr; 298(4):101653. PubMed ID: 35101445
[TBL] [Abstract][Full Text] [Related]
7. Discovery of E3 Ligase Ligands for Target Protein Degradation.
Lee J; Lee Y; Jung YM; Park JH; Yoo HS; Park J
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235052
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in PROTACs for Drug Targeted Protein Research.
Yao T; Xiao H; Wang H; Xu X
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142231
[TBL] [Abstract][Full Text] [Related]
9. Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization.
Schwalm MP; Krämer A; Dölle A; Weckesser J; Yu X; Jin J; Saxena K; Knapp S
Cell Chem Biol; 2023 Jul; 30(7):753-765.e8. PubMed ID: 37354907
[TBL] [Abstract][Full Text] [Related]
10. PROTAC-DB: an online database of PROTACs.
Weng G; Shen C; Cao D; Gao J; Dong X; He Q; Yang B; Li D; Wu J; Hou T
Nucleic Acids Res; 2021 Jan; 49(D1):D1381-D1387. PubMed ID: 33010159
[TBL] [Abstract][Full Text] [Related]
11. Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach.
Chen Q; Liu C; Wang W; Meng X; Cheng X; Li X; Cai L; Luo L; He X; Qu H; Luo J; Wei H; Gao S; Liu G; Wan J; Israel DI; Li J; Dou D
ACS Chem Biol; 2023 Jan; 18(1):25-33. PubMed ID: 36606710
[TBL] [Abstract][Full Text] [Related]
12. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
Ishida T; Ciulli A
SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
[TBL] [Abstract][Full Text] [Related]
13. Methods for computer-assisted PROTAC design.
Rovers E; Schapira M
Methods Enzymol; 2023; 690():311-340. PubMed ID: 37858533
[TBL] [Abstract][Full Text] [Related]
14. E3 ligase ligand chemistries: from building blocks to protein degraders.
Sosič I; Bricelj A; Steinebach C
Chem Soc Rev; 2022 May; 51(9):3487-3534. PubMed ID: 35393989
[TBL] [Abstract][Full Text] [Related]
15. New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation.
Wang X; Feng S; Fan J; Li X; Wen Q; Luo N
Biochem Pharmacol; 2016 Sep; 116():200-9. PubMed ID: 27473774
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis-targeting chimeras (PROTACs) in cancer therapy.
Li X; Pu W; Zheng Q; Ai M; Chen S; Peng Y
Mol Cancer; 2022 Apr; 21(1):99. PubMed ID: 35410300
[TBL] [Abstract][Full Text] [Related]
17. PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.
Khan S; He Y; Zhang X; Yuan Y; Pu S; Kong Q; Zheng G; Zhou D
Oncogene; 2020 Jun; 39(26):4909-4924. PubMed ID: 32475992
[TBL] [Abstract][Full Text] [Related]
18. ELIOT: A platform to navigate the E3 pocketome and aid the design of new PROTACs.
Palomba T; Baroni M; Cross S; Cruciani G; Siragusa L
Chem Biol Drug Des; 2023 Jan; 101(1):69-86. PubMed ID: 35857806
[TBL] [Abstract][Full Text] [Related]
19. An In Vitro Pull-down Assay of the E3 Ligase:PROTAC:Substrate Ternary Complex to Identify Effective PROTACs.
Bondeson DP; Smith BE; Buhimschi AD
Methods Mol Biol; 2021; 2365():135-150. PubMed ID: 34432242
[TBL] [Abstract][Full Text] [Related]
20. Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta.
Bai N; Miller SA; Andrianov GV; Yates M; Kirubakaran P; Karanicolas J
J Chem Inf Model; 2021 Mar; 61(3):1368-1382. PubMed ID: 33625214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
